WallStreetZenWallStreetZen

NYSEMKT: CVM
Cel Sci Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their CVM stock forecasts and price targets.

Forecast return on equity

Is CVM forecast to generate an efficient return?

Company
-411.62%
Industry
11.71%
Market
329.83%
CVM's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CVM forecast to generate an efficient return on assets?

Company
-142.19%
Industry
12.54%
CVM is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CVM earnings per share forecast

What is CVM's earnings per share in the next 1 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$4.20

CVM revenue forecast

What is CVM's revenue in the next 1 years based on estimates from 2 analysts?

Avg 1 year Forecast
$0.0

CVM vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CVM$6.36N/AN/A
IBIO$1.94$4.00+106.19%Strong Buy
BTAI$2.01$26.67+1,226.72%Buy
TAOX$6.02N/AN/A
GLTO$32.00$36.00+12.50%Strong Buy
View Top Biotech Stocks

Cel Sci Stock Forecast FAQ

What is CVM's earnings growth forecast for 2026-2026?

(NYSEMKT: CVM) Cel Sci's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 207.38%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,953.18%.

Cel Sci's earnings in 2025 is -$25,419,647.

In 2026, CVM is forecast to generate -$28,916,067 in earnings, with the lowest earnings forecast at -$28,057,174 and the highest earnings forecast at -$30,061,257.

If you're new to stock investing, here's how to buy Cel Sci stock.

What is CVM's revenue growth forecast for 2026-2026?

(NYSEMKT: CVM) Cel Sci's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 9,608.75%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,453.97%.

Cel Sci's revenue in 2025 is $0.

In 2026, CVM is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is CVM's forecast return on assets (ROA) for 2026-2026?

(NYSEMKT: CVM) forecast ROA is -142.19%, which is lower than the forecast US Biotechnology industry average of 12.54%.

What is CVM's Earnings Per Share (EPS) forecast for 2026-2026?

(NYSEMKT: CVM) Cel Sci's current Earnings Per Share (EPS) is -$9.04. In 2026, CVM's EPS is forecast to hit -$4.20 (min: -$4.08, max: -$4.37).

What is CVM's forecast return on equity (ROE) for 2026-2026?

(NYSEMKT: CVM) forecast ROE is -411.62%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.